Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.
Stem Cell Therapy for the Treatment of Hip Osteonecrosis: A 30-Year Review of Progress.
复制标题
DOI：
10.4055/cios.2016.8.1.1
复制
发表时间：
2016-03
影响因子：
2.5
通讯作者：
Flouzat-Lachaniette CH
中科院分区：
文献类型：
--
作者：
Hernigou P;Trousselier M;Roubineau F;Bouthors C;Chevallier N;Rouard H;Flouzat-Lachaniette CH
股骨头缺血性坏死是由多种病因引起的，并与塌陷有关，在年轻人群中存在髋关节置换术的风险。早在1985年，资深作者（PH）就提出了使用干细胞进行早期疾病管理的重点。我们对过去30年来细胞疗法治疗早期骨坏死的医学文献进行了系统回顾。
Avascular necrosis of the femoral head is caused by a multitude of etiologic factors and is associated with collapse with a risk of hip arthroplasty in younger populations. A focus on early disease management with the use of stem cells was proposed as early as 1985 by the senior author (PH). We undertook a systematic review of the medical literature to examine the progress in cell therapy during the last 30 years for the treatment of early stage osteonecrosis.